| Understanding the role of the gut microbiome and microbial metabolites in obesity and obesity-associated metabolic disorders: current evidence and perspectives N Vallianou, T Stratigou, GS Christodoulatos, M Dalamaga Current obesity reports 8, 317-332, 2019 | 300 | 2019 |
| Probiotics, prebiotics, synbiotics, postbiotics, and obesity: current evidence, controversies, and perspectives N Vallianou, T Stratigou, GS Christodoulatos, C Tsigalou, M Dalamaga Current obesity reports 9, 179-192, 2020 | 217 | 2020 |
| Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives N Vallianou, GS Christodoulatos, I Karampela, D Tsilingiris, F Magkos, ... Biomolecules 12 (1), 56, 2021 | 204 | 2021 |
| Vitamin D and obesity: current evidence and controversies I Karampela, A Sakelliou, N Vallianou, GS Christodoulatos, F Magkos, ... Current obesity reports 10, 162-180, 2021 | 189 | 2021 |
| Deciphering the association between psoriasis and obesity: current evidence and treatment considerations K Paroutoglou, E Papadavid, GS Christodoulatos, M Dalamaga Current obesity reports 9, 165-178, 2020 | 100 | 2020 |
| The role of adipokines in breast cancer: current evidence and perspectives GS Christodoulatos, N Spyrou, J Kadillari, S Psallida, M Dalamaga Current obesity reports 8, 413-433, 2019 | 95 | 2019 |
| Is there an obesity paradox in critical illness? Epidemiologic and metabolic considerations I Karampela, E Chrysanthopoulou, GS Christodoulatos, M Dalamaga Current obesity reports 9, 231-244, 2020 | 86 | 2020 |
| The role of extracellular and intracellular Nicotinamide phosphoribosyl-transferase in cancer: Diagnostic and therapeutic perspectives and challenges M Dalamaga, GS Christodoulatos, CS Mantzoros Metabolism 82, 72-87, 2018 | 84 | 2018 |
| Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis? GS Christodoulatos, M Dalamaga World journal of clinical oncology 5 (2), 71, 2014 | 82 | 2014 |
| Understanding the co-epidemic of obesity and COVID-19: current evidence, comparison with previous epidemics, mechanisms, and preventive and therapeutic perspectives M Dalamaga, GS Christodoulatos, I Karampela, N Vallianou, CM Apovian Current obesity reports 10 (3), 214-243, 2021 | 71 | 2021 |
| Mycobiome and cancer: what is the evidence? N Vallianou, D Kounatidis, GS Christodoulatos, F Panagopoulos, ... Cancers 13 (13), 3149, 2021 | 69 | 2021 |
| The role of adipose tissue and adipokines in sepsis: inflammatory and metabolic considerations, and the obesity paradox I Karampela, GS Christodoulatos, M Dalamaga Current obesity reports 8, 434-457, 2019 | 69 | 2019 |
| The role of next-generation probiotics in obesity and obesity-associated disorders: current knowledge and future perspectives NG Vallianou, D Kounatidis, D Tsilingiris, F Panagopoulos, ... International Journal of Molecular Sciences 24 (7), 6755, 2023 | 60 | 2023 |
| Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies M Dalamaga, GS Christodoulatos Hormone molecular biology and clinical investigation 23 (1), 5-20, 2015 | 58 | 2015 |
| Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with … I Karampela, E Kandri, G Antonakos, E Vogiatzakis, GS Christodoulatos, ... Journal of critical care 41, 78-85, 2017 | 50 | 2017 |
| Hyperirisinemia is independently associated with subclinical hypothyroidism: correlations with cardiometabolic biomarkers and risk factors T Stratigou, M Dalamaga, G Antonakos, I Marinou, E Vogiatzakis, ... Endocrine 61, 83-93, 2018 | 49 | 2018 |
| Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic NG Vallianou, D Tsilingiris, GS Christodoulatos, Ι Karampela, ... Metabolism open 10, 100096, 2021 | 42 | 2021 |
| Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer GP Sotiropoulos, M Dalamaga, G Antonakos, I Marinou, E Vogiatzakis, ... Lung Cancer 125, 291-299, 2018 | 40 | 2018 |
| Circulating eNampt and resistin as a proinflammatory duet predicting independently mortality in critically ill patients with sepsis: a prospective observational study I Karampela, GS Christodoulatos, E Kandri, G Antonakos, E Vogiatzakis, ... Cytokine 119, 62-70, 2019 | 39 | 2019 |
| Laboratory findings and biomarkers in long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and challenges D Tsilingiris, NG Vallianou, I Karampela, GS Christodoulatos, ... International journal of molecular sciences 24 (13), 10458, 2023 | 37 | 2023 |
Maria Dalamaga, MD, MSc (Harvard),...National and Kapodistrian University of Athens, Medical SchoolVahvistettu sähköpostiosoite verkkotunnuksessa med.uoa.gr